Subretinal Fluid Resolution and Visual Acuity in Patients with Neovascular Age-Related Macular Degeneration
Authors:
Open Access
- 30 May 2022
- journal article
- research article
- Published by Elsevier in Ophthalmology Retina
- Vol. 6 (11) , 1054-1060
Abstract
No abstract availableKeywords
Funding Information
- Genentech
This publication has 12 references indexed in Scilit:
- Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendationsEye, 2021
- Associations of Variation in Retinal Thickness With Visual Acuity and Anatomic Outcomes in Eyes With Neovascular Age-Related Macular Degeneration Lesions Treated With Anti–Vascular Endothelial Growth Factor AgentsJAMA Ophthalmology, 2020
- Association between visual acuity, lesion activity markers and retreatment decisions in neovascular age-related macular degenerationEye, 2020
- Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend RegimenOphthalmology, 2019
- Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular DegenerationOphthalmology, 2018
- Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular DegenerationOphthalmology, 2014
- Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular DegenerationOphthalmology, 2013
- Central retinal thickness measured with HD-OCT shows a weak correlation with visual acuity in eyes with CSMEBritish Journal of Ophthalmology, 2010
- Anti-VEGF Agents in the Treatment of Neovascular Age-related Macular Degeneration: Applying Clinical Trial Results to the Treatment of Everyday PatientsAmerican Journal of Ophthalmology, 2007
- Relationship between Optical Coherence Tomography–Measured Central Retinal Thickness and Visual Acuity in Diabetic Macular EdemaOphthalmology, 2007